Apathy may herald cognitive decline and dementia in Parkinson's disease

Movement Disorders

Volumn 24, Issue 16, 2009, Pages 2391-2397

  Dujardin, Kathy ^a,b   Sockeel, Pascal ^a,c   Delliaux, Marie ^b   Destée, Alain ^a,b   Defebvre, Luc ^a,b  

^a UNIV LILLE   (France)

^b Lille University Medical Center   (France)

^c Psychology Department   (France)

Author keywords

Apathy; Basal ganglia; Cognition; Dementia

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; APATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MALE; MEMORY DISORDER; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 73949158743     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22843     Document Type: Article

References (36)

1. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:492-496.
2. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-139.
3. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:636-642.
4. Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology 2006;67:33-38.
5. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007;22:778-784.
6. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002;40:2257-2267.
7. Aalten P, Verhey FR, Boziki M, et al. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: Part I. Dement Geriatr Cogn Disord 2007; 24:457-463.
8. Benoit M, Andrieu S, Lechowski L, Gillette-Guyonnet S, Robert PH, Vellas B. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription. Int J Geriatr Psychiatry 2008;23:409-414.
9. Robert PH, Berr C, Volteau M, et al. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study. Clin Neurol Neurosurg 2006;108:733-736.
10. Robert PH, Berr C, Volteau M, et al; PréAL study. Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry 2008;16:770-776.
11. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
12. Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 2006;21:148-158.
13. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007;22:1689-1707; quiz 1837.
14. Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001;158:872-877.
15. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:579-584.
16. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasy T, eds. Geriatric Psychiatry. New York: Grune and Stratton, 1976:77-121.
17. Van der Linden M, Coyette F, Poitrenaud J, et al. L'épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In: Van der Linden M, GREMEM, editors. L'évaluation des troubles de la mémoire. Marseille: Solal, 2004:25-47.
18. Smith A. Symbol Digit Modalities Test (SDMT). Western Psychological Services: Western Psychological Services; 1982.
19. Dujardin K, Defebvre L, Grunberg C, Becquet E, Destee A. Memory and executive function in sporadic and familial Parkinson's disease. Brain 2001;124(Pt 2):389-398.
20. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology 2001;57(10 Suppl 3):S11-S26.
22. Fahn S, Elton R, UPDRS, Development, Committee, Members. The Unified Parkinson's disease rating scale. In: Fahn S, Marsden C, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan healthcare; 1987. p 153-163.
23. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006;16: 916-928.
24. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual review of neuroscience 1986;9:357-381.
25. Janvin C, Aarsland D, Larsen JP, Hugdahl K. Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 2003;15:126-131.
26. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-1277.
27. Dubois B. Is PD-MCI a useful concept? Mov Disord 2007;22: 1215-1216.
28. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neuroscience and biobehavioral reviews 2006;30:1-23.
29. Jellinger KA. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Molecular and chemical neuropathology/ sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1991;14:153-197.
30. Figiel G, Sadowsky C. A systematic review of the effectiveness of rivastigmine for the treatment of behavioral disturbances in dementia and other neurological disorders. Current medical research and opinion 2008;24:157-166.
31. Wynn ZJ, Cummings JL. Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease. Dementia and geriatric cognitive disorders 2004;17:100-108.
32. Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Archives of neurology 1995;52:1164-1169.
33. Norman S, Troster AI, Fields JA, Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. The Journal of neuropsychiatry and clinical neurosciences 2002;14:31-36.
34. Pedersen KF, Larsen JP, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord 2009;15:295-9.
35. Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 2008;70:1017-1022.
36. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004;110:118-123.